Home/Filings/4/A/0001255541-17-000002
4/A//SEC Filing

Guardion Health Sciences, Inc. 4/A

Accession 0001255541-17-000002

CIK 0001642375operating

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:02 PM ET

Size

8.8 KB

Accession

0001255541-17-000002

Insider Transaction Report

Form 4/AAmended
Period: 2016-12-31
FAVISH MICHAEL
DirectorChair, Chief Executive Officer10% Owner
Transactions
  • Award

    Common Stock

    2016-12-31+50,0005,550,000 total(indirect: By Trust)
  • Purchase

    Common Stock

    2016-12-31$0.60/sh+684,933$410,9606,234,933 total(indirect: By Trust)
  • Award

    Common Stock

    2016-12-31+10,000260,000 total(indirect: By Spouse)
Footnotes (4)
  • [F1]The Board of Directors removed the vesting requirement such that the shares vest immediately upon issuance.
  • [F2]Private purchase of Common Stock by exchanging amounts accrued and owed to Michael Favish.
  • [F3]Grant of restricted stock issue to wife, Karen M. Favish, for services. The Board of Directors removed the vesting requirement such that the shares vest immediately upon issuance.
  • [F4]Corrected amount from Form 4 filed on 01/03/2017

Issuer

Guardion Health Sciences, Inc.

CIK 0001642375

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001642375

Filing Metadata

Form type
4/A
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:02 PM ET
Size
8.8 KB